FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200212552> ?p ?o ?g. }

• W4200212552 abstract "Ulotaront, a trace amine-associated receptor 1 (TAAR1) and serotonin 5-HT1A receptors agonist, has demonstrated efficacy in the treatment of patients with an acute exacerbation of schizophrenia in a 4-week, double-blind, placebo-controlled study. The aim of this 26-week open-label extension study was to evaluate the safety and effectiveness of ulotaront (25/50/75 mg/d) in patients who completed the initial 4-week study. Of the 193 4-week completers, 157 patients (81.3%) continued into the open-label extension study; 66.9% were completers. Among all extension phase patients, treatment with ulotaront was associated with minimal changes in body weight (mean [SD] change from double-blind baseline: -0.3 [3.7] kg), cholesterol (median change, -2.0 mg/dL), triglycerides (median, -5.0 mg/dL), and prolactin (female, median, -3.4 ng/mL; male, median, -2.7 ng/mL). Movement disorder scales showed no extrapyramidal effects. Twenty-six weeks of extension phase treatment was associated with a mean (95% CI) observed change from open-label baseline in the PANSS total score of -22.6 (-25.6, -19.6; effect size, 1.46), and a mean (95% CI) change in the CGI-Severity score of -1.0 (-1.2, -0.8; effect size, 1.07). Long-term treatment with the TAAR1 agonist ulotaront, in the daily dose range of 25-75 mg, was characterized by a relatively high completion rate, an adverse event profile notable for the absence of extrapyramidal-related adverse effects, a low liability for adverse weight and metabolic effects, and no effect on prolactin levels. Additional studies are needed to further confirm the long-term efficacy and safety of ulotaront." @default.
• W4200212552 created "2021-12-31" @default.
• W4200212552 creator A5004009842 @default.
• W4200212552 creator A5038805449 @default.
• W4200212552 creator A5056944189 @default.
• W4200212552 creator A5063897129 @default.
• W4200212552 creator A5066553937 @default.
• W4200212552 creator A5079968486 @default.
• W4200212552 creator A5084126298 @default.
• W4200212552 date "2021-12-09" @default.
• W4200212552 modified "2023-10-16" @default.
• W4200212552 title "Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study" @default.
• W4200212552 cites W1131918563 @default.
• W4200212552 cites W1964510658 @default.
• W4200212552 cites W1967158391 @default.
• W4200212552 cites W1967550266 @default.
• W4200212552 cites W1979797229 @default.
• W4200212552 cites W1981740077 @default.
• W4200212552 cites W1999320625 @default.
• W4200212552 cites W1999689270 @default.
• W4200212552 cites W2011675347 @default.
• W4200212552 cites W2012520776 @default.
• W4200212552 cites W2048867733 @default.
• W4200212552 cites W2058941601 @default.
• W4200212552 cites W2077622066 @default.
• W4200212552 cites W2085926691 @default.
• W4200212552 cites W2096192353 @default.
• W4200212552 cites W2114801996 @default.
• W4200212552 cites W2131823335 @default.
• W4200212552 cites W2140606211 @default.
• W4200212552 cites W2142137999 @default.
• W4200212552 cites W2148083007 @default.
• W4200212552 cites W2151487996 @default.
• W4200212552 cites W2155945003 @default.
• W4200212552 cites W2159155203 @default.
• W4200212552 cites W2162707091 @default.
• W4200212552 cites W2165379748 @default.
• W4200212552 cites W2166033924 @default.
• W4200212552 cites W2613459819 @default.
• W4200212552 cites W2754685807 @default.
• W4200212552 cites W2964999518 @default.
• W4200212552 cites W3015204490 @default.
• W4200212552 cites W3022484871 @default.
• W4200212552 cites W3096063139 @default.
• W4200212552 cites W3121060738 @default.
• W4200212552 cites W3152702086 @default.
• W4200212552 cites W3155391591 @default.
• W4200212552 cites W4247665917 @default.
• W4200212552 cites W4254230094 @default.
• W4200212552 doi "https://doi.org/10.1038/s41537-021-00190-z" @default.
• W4200212552 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34887427" @default.
• W4200212552 hasPublicationYear "2021" @default.
• W4200212552 type Work @default.
• W4200212552 citedByCount "29" @default.
• W4200212552 countsByYear W42002125522021 @default.
• W4200212552 countsByYear W42002125522022 @default.
• W4200212552 countsByYear W42002125522023 @default.
• W4200212552 crossrefType "journal-article" @default.
• W4200212552 hasAuthorship W4200212552A5004009842 @default.
• W4200212552 hasAuthorship W4200212552A5038805449 @default.
• W4200212552 hasAuthorship W4200212552A5056944189 @default.
• W4200212552 hasAuthorship W4200212552A5063897129 @default.
• W4200212552 hasAuthorship W4200212552A5066553937 @default.
• W4200212552 hasAuthorship W4200212552A5079968486 @default.
• W4200212552 hasAuthorship W4200212552A5084126298 @default.
• W4200212552 hasBestOaLocation W42002125521 @default.
• W4200212552 hasConcept C118552586 @default.
• W4200212552 hasConcept C126322002 @default.
• W4200212552 hasConcept C142724271 @default.
• W4200212552 hasConcept C170493617 @default.
• W4200212552 hasConcept C197934379 @default.
• W4200212552 hasConcept C204787440 @default.
• W4200212552 hasConcept C27081682 @default.
• W4200212552 hasConcept C2776412080 @default.
• W4200212552 hasConcept C2777014857 @default.
• W4200212552 hasConcept C2778938600 @default.
• W4200212552 hasConcept C2780494398 @default.
• W4200212552 hasConcept C2780616385 @default.
• W4200212552 hasConcept C3019800554 @default.
• W4200212552 hasConcept C42219234 @default.
• W4200212552 hasConcept C58732023 @default.
• W4200212552 hasConcept C71924100 @default.
• W4200212552 hasConcept C90924648 @default.
• W4200212552 hasConceptScore W4200212552C118552586 @default.
• W4200212552 hasConceptScore W4200212552C126322002 @default.
• W4200212552 hasConceptScore W4200212552C142724271 @default.
• W4200212552 hasConceptScore W4200212552C170493617 @default.
• W4200212552 hasConceptScore W4200212552C197934379 @default.
• W4200212552 hasConceptScore W4200212552C204787440 @default.
• W4200212552 hasConceptScore W4200212552C27081682 @default.
• W4200212552 hasConceptScore W4200212552C2776412080 @default.
• W4200212552 hasConceptScore W4200212552C2777014857 @default.
• W4200212552 hasConceptScore W4200212552C2778938600 @default.
• W4200212552 hasConceptScore W4200212552C2780494398 @default.
• W4200212552 hasConceptScore W4200212552C2780616385 @default.
• W4200212552 hasConceptScore W4200212552C3019800554 @default.
• W4200212552 hasConceptScore W4200212552C42219234 @default.
• W4200212552 hasConceptScore W4200212552C58732023 @default.
• W4200212552 hasConceptScore W4200212552C71924100 @default.
• W4200212552 hasConceptScore W4200212552C90924648 @default.

• next